Posts by holdings2017bb

Aspen signs R10 billion deal with MSD

Oss, Netherlands – JSE Limited listed Aspen Holdings is pleased to announce that the Aspen Group (“Aspen”), the ninth largest generic pharmaceutical company in the world, has: signed an agreement with MSD (known as Merck in the United States and Canada) for the acquisition of an active pharmaceutical ingredient (“API”) manufacturing business which manufactures for…

Read More

Aspen to invest more than R1,9 billion in infant nutritional deal with Pfizer

Shareholders of Aspen Holdings are advised that Aspen Group companies (“Aspen”) have concluded agreements with Nestlé S.A. in respect of the acquisition of certain rights to intellectual property licenses, net assets and shares in the IN businesses presently conducted by Pfizer which distribute a portfolio of IN products in Australia (the “Australian IN business”) and…

Read More

Aspen increases revenue to R9 billion

JSE Limited listed Aspen Pharmacare Holdings Limited (Apn), the ninth largest generic company in the world and Africa’s largest pharmaceutical manufacturer, has announced excellent results for the interim period ended 31 December 2012. Group Performance Revenue from continuing operations increased by 20% to R9.0 billion. Operating profit from continuing operations rose by 24% to R2.5…

Read More

Renewal of Cautionary Announcement

Shareholders are referred to the cautionary announcement released by Aspen on 4 February 2013 (and subsequent renewals of this cautionary announcement) in which shareholders were advised of discussions between Aspen and MSD, known as Merck in the United States and Canada, in respect of a possible transaction comprising the acquisition of an active pharmaceutical ingredient…

Read More

Cautionary Announcement – Discussions with MSD

ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) Registration number 1985/0002935/06 Share code: APN ISIN: ZAE000066692 (“Aspen” or “the Company”) CAUTIONARY ANNOUNCEMENT – DISCUSSIONS WITH MSD Shareholders are advised that Aspen is currently engaged in discussions with MSD (known as Merck in the United States and Canada) in respect of a possible…

Read More

Stephen Saad named as Business Leader of the Year

STEPHEN SAAD AWARDED BUSINESS LEADER OF THE YEAR TITLE Johannesburg: Aspen Group Chief Executive, Stephen Saad, was named as the Business Leader of the Year at the annual Sunday Times Top 100 Companies banquet last night. Durban-based Stephen, who graduated from the University of Natal in 1986 with a B.Com and later qualified as a…

Read More

Aspen’s revenue increases by 23%

JSE Ltd listed Aspen Pharmacare Holdings Limited (APN), Africa’s largest pharmaceutical manufacturer, has announced pleasing results for the year ended 30 June 2012, extending its record of growth for a fourteenth consecutive year. Group Performance Revenue from continuing operations rose by 23 percent to R15.3 billion. Operating profit from continuing operations increased by 25 percent…

Read More

Aspen Trading Statement

APN – Aspen Pharmacare Holdings Limited – Trading statement Aspen Pharmacare Holdings Limited (Incorporated in the Republic of South Africa) (Registration number 1985/002935/06) Share code: APN & ISIN: ZAE000066692 (“Aspen”) Trading statement Aspen’s shareholders are hereby advised that diluted normalised headline earnings per share from continuing operations, headline earnings per share (“HEPS”) and earnings per…

Read More

Aspen Global acquires Australian product portfolio for R2.2 billion

ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) Registration number: 1985/0002935/06 Share code: APN ISIN: ZAE000066692 (“Aspen Holdings”) The Aspen Group (“Aspen”) is pleased to announce that Aspen Global Incorporated (“Aspen Global”), a wholly owned subsidiary of Aspen Holdings, has reached agreement with GlaxoSmithKline plc (“GSK”) for the acquisition of a portfolio…

Read More

Judy Dlamini, Aspen’s Chairman’s Upper Echelon interview

“I actually want to work until the very last day of my life”, Judy Dlamini ALEC HOGG: Upper Echelon is brought to you by Deloitte – for innovative thinking and thorough strategic planning turn to Deloitte. In our Upper Echelon this week, Judy Dlamini, chair of Mbekani Investment Holdings and better known through her chair…

Read More

Aspen businesses activate 29 Mandela Day projects globally

Durban: Aspen, one of the world’s top 10 generic pharmaceutical companies by revenue and the largest pharmaceutical manufacturer in the southern hemisphere, is activating 29 projects across 11 countries on 6 continents in celebration of 2012 Nelson Mandela International Day (“Mandela Day”). Stephen Saad, Aspen Group Chief Executive said, “We have embraced Mandela Day across…

Read More

Stephen Saad raises R10 million for children

Health Minister supports Stephen Saad’s initiative as he raises R10m for children Durban: Health Minister Dr Aaron Motsoaledi’s support of the Sifiso Nxasana Paediatric Trust for the Children of Africa (“the Trust”), which is raising funds for paediatric hospitals, is paying off with R10 million already raised. The campaign was recently launched by pharmaceutical entrepreneur…

Read More